Eurofins CDMO Alphora Inc., operating as part of Eurofins CDMO, is a leading provider of Active Pharmaceutical Ingredient and Drug Product development and manufacturing services for complex small molecules, including highly potent compounds. As a campus style facility, we offer API and Drug Product Development services as a fully integrated solution or as stand-alone services. As an FDA & Health Canada approved CDMO, we specialize in process chemistry, analytical method development and non-cGMP & cGMP API scale-up. Through the integration of synthetic Process R&D, Solid State R&D, and Formulation Development, we offer a full suite of drug development services and manufacturing capabilities to support pre-clinical to commercial success. Our Drug Product operations can support development and clinical manufacturing of oral solid dosage forms and complements our existing API development & manufacturing services by providing enhanced quick-to-clinic drug product strategy designed to meet clients' needs for Phase I and II products.Our services include:• Drug Substance/API Development• Solid State Research & Development• Drug Product Operations (Pre-Formulation & Formulation Development)• Analytical Development & Validation• Clinical Packaging and Logistics• Project Management• CMC & Regulatory Services• Process Development• DoE and QbD• Stability Testing• Gram to Kilogram Synthesis• cGMP and non-cGMP• High Potency• Fast Track services• Flow Chemistry